Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. The company is headquartered in Quincy, Florida. The company went IPO on 2018-09-25. The firm has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Each of its three regional hubs is anchored by market positions in the cornerstone states of Florida, Pennsylvania, and Arizona. The firm operates in regulated markets that require expertise in cultivation, manufacturing, and retail. The firm utilizes various extraction techniques, including supercritical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, it utilizes distillation, purification, and manufacturing technologies to further refine extracts and transform them into a wide variety of finished products. Its brands include premium-tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.
Western Asset High Income Fund II Inc の最大収益セグメントは Specialty Chemicals で、最新の利益発表における収益は 74,942,000 です。地域別に見ると、United States が Western Asset High Income Fund II Inc の主要市場であり、収益は 70,495,000 です。
Trulieve Cannabis Corp.は収益を上げていますか?
いいえ、最新の財務諸表によると、Western Asset High Income Fund II Incの純損失は$0です。
Trulieve Cannabis Corp.に負債はありますか?
いいえ、Western Asset High Income Fund II Incの負債は0です。
Trulieve Cannabis Corp.の発行済株式数は何株ですか?
Western Asset High Income Fund II Incの総発行済株式数は0株です。